Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Transforming Personalised Acute Myeloid Leukaemia Therapy through an Integrative European Multi-Centre Multi-Omics Network
| Reference number | 2025-00311 |
| Coordinator | Karolinska Institutet |
| Funding from Vinnova | SEK 2 967 777 |
| Project duration | January 2026 - December 2028 |
| Status | Ongoing |
| Venture | European partnership for Personalised Medicine |
| Call | International collaboration in pharmacogenomics in personalised medicine |
Last updated 4 December 2025
Reference number 2025-00311
